Skip to main content
. 2022 Jun 24;13:832199. doi: 10.3389/fneur.2022.832199

Table 2.

Prevalence of BPSD in the whole sample and in AD and bvFTD groups.

Prevalence p ϕ
BPSD Total AD bvFTD
Delusions 26.4 24.8 30.7 0.003* 0.059
Hallucinations 28.1 27.5 29.8 0.246 0.023
Agitation/aggression 44.2 42.3 49.7 0.001* 0.065
Depression 39.2 38.8 40.4 0.478 0.014
Anxiety 27.2 26.8 28.5 0.400 0.017
Euphoria 4.0 2.3 9.1 <0.001** 0.151
Apathy 61.9 57.4 74.6 <0.001** 0.155
Disinhibition 29 26.3 36.9 <0.001** 0.103
Irritability/affective lability 51.1 50.5 52.5 0.377 0.017
Aberrant motor behavior 13.1 10.6 20.3 <0.001** 0.126
Sleep/Nighttime behavior 38.7 35.6 47.6 <0.001** 0.108
Eating disorders 20.2 13.6 39.0 <0.001** 0.277
Wandering 10.2 7.5 17.7 <0.001** 0.147

Data are presented as %.

*

Significant difference (p < 0.05).

**

Significant difference (p < 0.001).